Complex issues pose challenges for life sciences companies


Life sciences company leaders planning for growth and stability in the coming year have plenty of issues and trends on which to focus. Regulatory changes, both domestically and internationally, must always be monitored. Advances in AI technology promise to have an increasingly larger impact on growth and operations. Mergers and acquisitions in the industry continue to require life sciences companies to be vigilant for opportunities.


In this podcast, Grant Thornton National Managing Partner for Life Sciences Zara Muradali discusses what she regards as the most important considerations life sciences leaders need to focus on in the coming year, including:

  • How high interest rates are affecting M&A opportunities
  • How pre-revenue life sciences companies are being affected by tax regulations and how to move toward solutions
  • Where AI will continue to affect life sciences companies in research, in relations with regulators, and in organization ethics

Find out what lies ahead for life sciences companies in 2024 in our latest industry series podcast.




Life Sciences Industry: Top issues of 2024


What are the top issues that leaders need to keep in mind for 2024?


6:58 |  Transcript

Zara Muradali

National Industry Managing Principal, Life Sciences, Grant Thornton



More resources





Zara Muradali

Zara is the National Industry Managing Principal of Grant Thornton’s Life Sciences practice.

Boston, Massachusetts

  • Life sciences
  • Healthcare
  • Technology, media & telecommunications
  • Private equity
Service Experience
  • Corporate Tax

Top issues for 2024 in other industries




Our life sciences featured industry insights